162 related articles for article (PubMed ID: 29935185)
1. Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-κB signaling pathway in hepatocellular carcinoma.
Huang Y; Chen G; Wang Y; He R; Du J; Jiao X; Tai Q
Biochem Biophys Res Commun; 2018 Sep; 503(2):1035-1041. PubMed ID: 29935185
[TBL] [Abstract][Full Text] [Related]
2. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
[TBL] [Abstract][Full Text] [Related]
3. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
Jia H; Yang Q; Wang T; Cao Y; Jiang QY; Ma HD; Sun HW; Hou MX; Yang YP; Feng F
Biochim Biophys Acta; 2016 Jul; 1860(7):1417-30. PubMed ID: 27091611
[TBL] [Abstract][Full Text] [Related]
4. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.
Tang X; Jin L; Cao P; Cao K; Huang C; Luo Y; Ma J; Shen S; Tan M; Li X; Zhou M
Oncotarget; 2016 Apr; 7(17):23668-83. PubMed ID: 26993770
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
Huang X; Qin J; Lu S
Int J Clin Exp Pathol; 2015; 8(2):1515-24. PubMed ID: 25973036
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.
Tu C; Chen W; Wang S; Tan W; Guo J; Shao C; Wang W
J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM
Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101
[TBL] [Abstract][Full Text] [Related]
10. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
[TBL] [Abstract][Full Text] [Related]
11. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
Zhao L; Zhang Y
Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance.
Meng W; Tai Y; Zhao H; Fu B; Zhang T; Liu W; Li H; Yang Y; Zhang Q; Feng Y; Chen G
Med Sci Monit; 2017 Mar; 23():1295-1304. PubMed ID: 28291769
[TBL] [Abstract][Full Text] [Related]
13. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
14. Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB/microRNA-21/PTEN signaling pathway.
Zhang K; Chen J; Chen D; Huang J; Feng B; Han S; Chen Y; Song H; De W; Zhu Z; Wang R; Chen L
Oncotarget; 2014 Dec; 5(24):12916-35. PubMed ID: 25428915
[TBL] [Abstract][Full Text] [Related]
15. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.
Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X
Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053
[TBL] [Abstract][Full Text] [Related]
16. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
Qin J; Luo M; Qian H; Chen W
Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
[TBL] [Abstract][Full Text] [Related]
17. Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression.
Liu X; Wang S; Xu J; Kou B; Chen D; Wang Y; Zhu X
BMC Complement Altern Med; 2018 Mar; 18(1):99. PubMed ID: 29554896
[TBL] [Abstract][Full Text] [Related]
18. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29-3p Regulates Hepatocellular Carcinoma Progression Through NF-κB Pathway.
Ma JH; Bu X; Wang JJ; Xie YX
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115237
[TBL] [Abstract][Full Text] [Related]
20. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
